• People
  • Practices
  • Insights
      • Insights
      • Technology & Innovation
      • Orrick Tech Studio
      • Energy & Infrastructure
      • Finance
      • Life Sciences & HealthTech
      • Litigation & IP
      • Strategic Advisory & Government Enforcement (SAGE)
      • All Insights
      • Featured
      • CFPB Pause: Where From Here?
      • The Download: Tech & Innovation Market Briefing
      • AI Law Center
      • Online Safety Law Center
      • Life Sciences Venture Capital Quarterly Report
      • Channels
      • Podcasts
      • Events
  • Careers
  • About
      • About
      • About Us
      • News
      • Locations
      • Innovation
      • AI Adoption @Orrick
      • Alumni
      • Responsible Business
      • Veterans' Legal Career Fair
      • Environmental Sustainability
      • Pro Bono
      • Inclusion & Belonging
  • Orrick Tech Studio
  • People
  • Practices
  • Insights
  • Careers
  • About
  • Orrick Tech Studio
  • Technology & Innovation
  • Energy & Infrastructure
  • Finance
  • Life Sciences & HealthTech
Orrick.com
 

People


Orrick.com
 

Practices


Orrick.com
 

Insights


  • Insights
  • Technology & Innovation
  • Orrick Tech Studio
  • Energy & Infrastructure
  • Finance
  • Life Sciences & HealthTech
  • Litigation & IP
  • Strategic Advisory & Government Enforcement (SAGE)
  • All Insights
  • Featured
  • CFPB Pause: Where From Here?
  • The Download: Tech & Innovation Market Briefing
  • AI Law Center
  • Online Safety Law Center
  • Life Sciences Venture Capital Quarterly Report
  • Channels
  • Podcasts
  • Events
Orrick.com
 

Careers


Orrick.com
 

About


  • About
  • About Us
  • News
  • Locations
  • Innovation
  • AI Adoption @Orrick
  • Alumni
  • Responsible Business
  • Veterans' Legal Career Fair
  • Environmental Sustainability
  • Pro Bono
  • Inclusion & Belonging
Orrick.com
 

Orrick Tech Studio


Orrick.com
 


Orrick.com
 

Technology & Innovation


Orrick.com
 

Energy & Infrastructure


Orrick.com
 

Finance


Orrick.com
 

Life Sciences & HealthTech


Orrick logo
  • Technology & Innovation
  • Energy & Infrastructure
  • Finance
  • Life Sciences & HealthTech
Submit
  1. Home
  2. Life Sciences & HealthTech
      • Facebook
      • Twitter
      • Linkedin

News & Client Results

  • Show more

Combatting Rare Pediatric Disease: Ipsen to Sell Priority Review Voucher

2 minute read | October.10.2024

pharmaceuticals_1

Ipsen has agreed to sell its rare pediatric disease priority review voucher to a large global pharmaceutical company for $158 million.

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. to Combine to Form Dogwood Therapeutics, Inc.

2 minute read | October.07.2024

digital germ
Virios Therapeutics plans to combine with Wex Pharmaceuticals in an all-stock transaction to form a combined company called Dogwood Therapeutics.

Managing IP Highlights Irena Royzman’s IP Work for the Life Science and Tech Sectors

1 minute read | September.10.2024

450076

Managing IP features Orrick IP partner Irena Royzman for her impact in shaping patent protections for life sciences and tech clients.

Laser Systems in Health Care: Afinum Investments Form MedTech Laser Group

1 minute read | July.31.2024

Afinum logo
European investment firm Afinum has formed MedTech Laser Group through its investment in German company A.R.C. Laser and Israeli company G.N.S. ...

Orrick Grows Life Sciences & HealthTech Platform with 7-Lawyer FDA and Healthcare Regulatory Team

6 minute read | July.11.2024

Life Sciences Team 2024 orrick
Welcome to a trio of leading FDA and healthcare regulatory advisors.

Tech and Life Sciences Companies Urge USPTO to Abandon Proposed Patent Rule

2 minute read | July.10.2024

IP Lightbulb in Hand

Orrick intellectual property team behind tech and life sciences effort to reverse proposed U.S. Patent and Trademark Office rule

Amicus Effort Backs Tech and Life Sciences Innovators in U.S. Supreme Court Case

1 minute read | June.25.2024

US Supreme Court
In case of major importance to the tech and life sciences sectors, an Orrick team urges U.S. Supreme Court to reverse patent decision in Cellect.

Federal Circuit Urged in Amicus to Protect Patent Rights of Biotech Innovators

1 minute read | May.15.2024

life sciences
Orrick life sciences team files amicus brief in major appellate case involving patent rights of biotechnology industry.

Advancing Effective Mental Healthcare: Grow Therapy Raises $88 Million

2 minute read | April.11.2024

earth_3

Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88 million funding round.

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc.

2 minute read | April.10.2024

Onconova Therapeutics logo

Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.

ImmunogenX Acquired by First Wave BioPharma

2 minute read | April.10.2024

ImmunogenX logo

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.

Events

  • Show more

Events

New York Intellectual Property Law Association’s (NYIPLA) Patent Seminar

Orrick Intellectual Property Partner, Irena Royzman, will be speaking at NYIPLA’s One-Day Patent CLE Seminar on November 7, 2024.

November.07.2024 | Hughes Hubbard & Reed LLP

Events

Women in AI and Healthcare Panel

Please join Team Orrick and the Women’s General Counsel Network (WGCN) for an insightful discussion centered around emerging trends in AI and healthcare. We'll explore how key topics impact women and uncover valuable insights through dynamic conversations. Following the program, we invite you to ...

September.10.2024 | Orrick San Francisco

Events

Fortifying Healthcare IT: Strategies to Protect Your Organization from Rising Class Action Lawsuits

Aravind Swaminathan will co-lead a discussion on the origin of the private right of action for privacy breaches, the effects, and where it’s going.

July.30.2024 | Virtual

Events

New Jersey Intellectual Property Law Association (NJIPLA) Patent Litigation Seminar 2024

On Thursday, May 16, 2024, Intellectual Property partner Irena Royzman will lead a presentation titled "Mandatory Clinical Trial Disclosures as Prior Art" at NJIPLA's 2024 Patent Litigation Seminar.

May.16.2024 | Gibbons P.C.

Events

Reception during the 2024 JP Morgan Healthcare Conference

In collaboration with Cathay Innovation and Horizon Technology Finance, we are co-hosting a networking reception to kick off the 2024 JP Morgan Healthcare Conference. From disruptive startups to investors, pharmaceutical leaders, healthcare innovators, payors and providers, join fellow leaders in ...

January.08.2024 | San Francisco, CA

Events

2023 Berkeley Center for Law & Technology (BCLT) Privacy Law Forum: Life Sciences

Orrick's Shannon Yavorsky will be co-leading a session at the BCLT Privacy Law Forum for Life Sciences exploring issues surrounding life sciences, technology and privacy legal regimes.

November.14.2023 | Virtual / B-CLE Webcast

  • Linkedin
  • Twitter
  • Facebook
  • Instagram
  • Legal Notices
  • Privacy Notice
  • Cookie Notice
  • Attorney Advertising
  • Secure Login

© 2025 Orrick, Herrington & Sutcliffe LLP. All rights reserved.

  • Austin
  • Beijing
  • Boston
  • Brussels
  • Chicago
  • Düsseldorf
  • Geneva
  • Houston
  • London
  • Los Angeles
  • Milan
  • Munich
  • New York
  • Orange County
  • Paris
  • Portland
  • Rome
  • Sacramento
  • San Francisco
  • Santa Monica
  • Seattle
  • Silicon Valley
  • Singapore
  • Tokyo
  • Washington, D.C.
  • Wheeling, W.V. (GOIC)

Please read before sending e-mail.

Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.

  • OK
  • Cancel